The Biosimilars Market continues to evolve rapidly with the growing acceptance of biosimilar medicines among physicians, healthcare providers, and patients. These therapies offer similar efficacy and safety as originator biologics while significantly lowering healthcare expenses. Increasing investments in biotechnology, rising prevalence of autoimmune disorders and cancer, supportive regulatory...